RxSight (RXST) Gross Profit Growth (1y) (2021 - 2026)
Powered by 
Analysis
RxSight (RXST) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 15.59% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 21.17% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 13.68% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 17.10% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.38% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.54% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 20.68% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 20.50% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.95% |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -17.05% |
| Dec 31, 2025 | -12.24% |
| Sep 30, 2025 | -3.94% |
| Jun 30, 2025 | 3.88% |
| Mar 31, 2025 | 36.95% |
| Dec 31, 2024 | 63.07% |
| Sep 30, 2024 | 83.67% |
| Jun 30, 2024 | 101.83% |
| Mar 31, 2024 | 99.55% |
| Dec 31, 2023 | 137.86% |
| Sep 30, 2023 | 156.37% |
| Jun 30, 2023 | 150.94% |
| Mar 31, 2023 | 175.62% |
| Dec 31, 2022 | 158.70% |
| Sep 30, 2022 | 299.40% |
| Jun 30, 2022 | 689.66% |
| Mar 31, 2022 | 236.10% |
| Dec 31, 2021 | 107.90% |
| Sep 30, 2021 | 86.25% |
| Jun 30, 2021 | -71.31% |